Trial record 1 of 8 for:    Leber congenital amaurosis phase 3
Previous Study | Return to List | Next Study

Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis

This study is currently recruiting participants.
Verified January 2014 by Spark Therapeutics, LLC
Sponsor:
Collaborators:
Children's Hospital of Philadelphia
University of Iowa
Information provided by (Responsible Party):
Spark Therapeutics, LLC
ClinicalTrials.gov Identifier:
NCT00999609
First received: October 21, 2009
Last updated: January 13, 2014
Last verified: January 2014